ERBB2 and neuroblastoma: Hsu et al. (2006) demonstrated that in neuroblastoma (B104-1–1) cells, the proto-oncogene HER-2/neu could inhibit RECK (a tumor metastasis suppressor) level through suppressing ERK and Sp1 transcription factor; eventually, it promoted cell invasion.